)
Tyra Biosciences (TYRA) investor relations material
Tyra Biosciences Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for May 28, 2026, to be held virtually for stockholders of record as of April 2, 2026.
Meeting materials include the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K.
Voting matters and shareholder proposals
Election of three Class II directors for a three-year term expiring at the 2029 annual meeting: Habib J. Dable, Susan Moran, and Robert More.
Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Other business may be transacted as properly brought before the meeting or any adjournment.
Board of directors and corporate governance
Board recommends a vote in favor of both director election and auditor ratification proposals.
- Shareholders will elect directors, ratify the auditor, and review executive pay and governance.TYRA
Proxy filing17 Apr 2026 - Oral Dabogratinib targets blockbuster potential in UTUC, NMIBC, and achondroplasia with pivotal data ahead.TYRA
TD Cowen 46th Annual Health Care Conference4 Mar 2026 - Focused on three pivotal clinical programs with robust cash runway and key data readouts in 2026.TYRA
Q4 20252 Mar 2026 - Phase II trials for dabogratinib target NMIBC, UTUC, and achondroplasia, with key data due this year.TYRA
Oppenheimer 36th Annual Healthcare Life Sciences Conference26 Feb 2026 - TYRA-300 advances in achondroplasia and oncology, with pivotal data and INDs due this year.TYRA
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Selective FGFR3 inhibitor targets efficacy and tolerability in large bladder cancer and achondroplasia markets.TYRA
2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026 - TYRA-300 shows 54.5% response and 100% disease control in FGFR3+ mUC with low toxicity.TYRA
Study Update18 Jan 2026 - Phase 2 trials in achondroplasia and NMIBC to start, with rapid safety and efficacy updates expected.TYRA
Jefferies London Healthcare Conference 202413 Jan 2026 - FGFR3-selective therapies show promise for safer, more effective treatment in cancer and achondroplasia.TYRA
Piper Sandler 36th Annual Healthcare Conference11 Jan 2026
Next Tyra Biosciences earnings date
Next Tyra Biosciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage